Notice Type
Departmental
Notice Title

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Dimethyl Fumarate Viatris
Active Ingredient: Dimethyl fumarate 120mg
Dosage Form: Modified release capsule
New Zealand Sponsor: Viatris Limited
Manufacturer: Mylan Laboratories Limited, Pithampur, India
   
Product: Dimethyl Fumarate Viatris
Active Ingredient: Dimethyl fumarate 240mg
Dosage Form: Modified release capsule
New Zealand Sponsor: Viatris Limited
Manufacturer: Mylan Laboratories Limited, Pithampur, India
   
Product: Lacosamide Te Arai
Active Ingredient: Lacosamide 10mg/mL
Dosage Form: Oral solution
New Zealand Sponsor: Te Arai BioFarma Limited
Manufacturer: Lichtenheldt GmbH, Wahlstedt, Germany
   
Product: Paracetamol 250mg/5mL
Active Ingredient: Paracetamol 50mg/mL
Dosage Form: Oral suspension
New Zealand Sponsor: Multichem NZ Limited
Manufacturer: Rubicon Research Pvt. Limited, Satara, India
   
Product: Vegzelma (100mg/1mL)
Active Ingredient: Bevacizumab 25mg/mL
Dosage Form: Concentrate for infusion
New Zealand Sponsor: Celltrion Healthcare New Zealand Limited
Manufacturer: Celltrion Inc., Incheon, South Korea
   
Product: Vegzelma (400mg/16mL)
Active Ingredient: Bevacizumab 25mg/mL
Dosage Form: Concentrate for infusion
New Zealand Sponsor: Celltrion Healthcare New Zealand Limited
Manufacturer: Celltrion Inc., Incheon, South Korea
   
Product: Vumerity
Active Ingredient: Diroximel fumarate 231mg
Dosage Form: Enteric coated capsule
New Zealand Sponsor: Biogen NZ Biopharma Limited
Manufacturer: Alkermes Pharma Ireland Limited, Athlone, Ireland


Dated this 23rd day of January 2024.

DEREK FITZGERALD, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).